Table 3.
Variable | Unadjusted OR (95% CI) for FIB-4 >3.25 |
p- value |
Adjusted OR (95% CI) for FIB- 4 >3.25 |
p- value |
Unadjusted OR (95% CI) for APRI >1.5 |
p-value | Adjusted OR (95% CI) for APRI >1.5 |
p- value |
---|---|---|---|---|---|---|---|---|
Model 1 | ||||||||
Lifetime alcohol consumption [kg of alcohol] (n=272) |
||||||||
<150 kg | 1 | 0.41 | 1 | 0.11 | 1 | 0.57 | 1 | 0.39 |
150–600 kg | 0.49 (0.17, 1.40) | 0.27 (0.07, 0.98) | 0.56 (0.18, 1.75) | 0.42 (0.12, 1.53) | ||||
>600 kg | 0.69 (0.28, 1.70) | 0.64 (0.23, 1.81) | 0.84 (0.31, 2.23) | 0.76 (0.26, 2.19) | ||||
Sex: | ||||||||
Female | 2.38 (0.91, 6.19) | 0.08 | 0.54 (0.17,1.75) | 0.31 | ||||
Male | 1 | 1 | ||||||
HCV infection (HCV RNA) |
3.39 (1.17, 9.78) | 0.02 | 5.16 (1.66, 16.06) | <0.01 | ||||
CD4 count [cells/mm3] | * | * | ||||||
<200 | 12.75 (2.45, 66.38) | <0.01 | 6.65 (1.61, 27.45) | <0.01 | ||||
200–500 | 7.54 (1.62, 35.04) | <0.01 | 3.55 (0.95, 13.30) | 0.06 | ||||
>500 | 1 | 1 | ||||||
Age [per additional year] | 1.08 (1.01, 1.15) | 0.02 | 1.04 (0.98, 1.11) | 0.24 | ||||
Model 2 | ||||||||
Heavy episodic drinking (n=282) |
||||||||
<9 years | 1 | 0.66 | 1 | 0.39 | 1 | 0.89 | 1 | 0.61 |
9–21 years | 0.86 (0.36, 2.05) | 1.28 (0.46, 3.51) | 0.98 (0.39, 2.47) | 1.25 (0.45, 3.47) | ||||
>21 years | 0.64 (0.24, 1.72) | 0.61 (0.21, 1.81) | 0.80 (0.28, 2.24) | 0.72 (0.24, 2.17) | ||||
Sex | ||||||||
Female | 1.98 (0.79, 4.69) | 0.14 | 0.45 (0.14, 1.43) | 0.18 | ||||
Male | 1 | 1 | ||||||
HCV infection (HCV RNA) |
4.18 (1.46, 11.92) | <0.01 | 6.41 (2.07, 19.80) | <0.01 | ||||
CD4 count [cells/mm3] | * | * | ||||||
<200 | 10.20 (1.99, 52.24) | <0.01 | 6.00 (1.47, 24.48) | 0.01 | ||||
200–500 | 8.27 (1.81, 37.92) | <0.01 | 4.07 (1.11, 14.94) | 0.03 | ||||
>500 | 1 | 1 | ||||||
Age [per additional year] | 1.07 (1.01, 1.14) | 0.02 | 1.04 (0.98, 1.10) | 0.24 | ||||
Model 3 | ||||||||
Heavy alcohol use [NIAAA definition] (last 30 days) (n=286) |
0.97 (0.44, 2.14) | 0.94 | 1.10 (0.45, 2.65) | 0.84 | 1.15 (0.51, 2.59) | 0.74 | 1.14 (0.47, 2.77) | 0.77 |
Sex: | ||||||||
Female | 1.85 (0.75, 4.55) | 0.18 | 0.44 (0.14, 1.37) | 0.15 | ||||
Male | 1 | 1 | ||||||
HCV infection (HCV RNA) |
4.35 (1.55, 12.19) | <0.01 | 6.55 (2.15, 19.97) | <0.01 | ||||
CD4 count [cells/mm3] | * | * | ||||||
<200 | 10.95 (2.20, 54.41) | <0.01 | 6.61 (1.65, 26.49) | 0.03 | ||||
200–500 | 7.90 (1.73, 35.95) | <0.01 | 4.07 (1.11, 14.93) | <0.01 | ||||
>500 | 1 | 1 | ||||||
Age [per additional year] | 1.06 (1.00, 1.13) | <0.05 | 1.03 (0.97, 1.10) | 0.33 |
HCV RNA: Hepatitis C virus Ribonucleic acid;
global p-value <0.05; OR (95% CI): Odds ratio (95% Confidence interval).